BlackRock Health Sciences Trust II (BMEZ)
NYSE: BMEZ · IEX Real-Time Price · USD
15.70
+0.11 (0.71%)
Jul 19, 2024, 4:00 PM EDT - Market open
Company Description
BlackRock Health Sciences Term Trust is a closed-end management investment company, which investment objectives are to provide total return and income through a combination of current income, current gains and long-term capital appreciation.
The company was founded on August 14, 2019 and is headquartered in Wilmington, DE.
BlackRock Health Sciences Trust II
| Country | United States |
| Industry | Asset Management |
| Sector | Financials |
| CEO | Jeffrey Gene Lee |
Contact Details
Address: 100 Bellevue Parkway Wilmington, Delaware 19809 United States | |
| Phone | 800 882 0052 |
Stock Details
| Ticker Symbol | BMEZ |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001785971 |
| CUSIP Number | 09260E105 |
| ISIN Number | US09260E1055 |
Key Executives
| Name | Position |
|---|---|
| Jeffrey Gene Lee | Portfolio Manager |
| Dr. Xiang Liu Ph.D. | Portfolio Manager |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 18, 2024 | SC TO-I | Filing |
| Jul 2, 2024 | SC TO-C | Filing |
| Jun 21, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Jun 18, 2024 | DFAN14A | Filing |
| Jun 17, 2024 | DFAN14A | Filing |
| Jun 14, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Jun 14, 2024 | DFAN14A | Filing |
| Jun 14, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Jun 13, 2024 | DFAN14A | Filing |
| Jun 13, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |